Arceci / Hann / Smith Pediatric Hematology

3. Auflage 2008
ISBN: 978-0-470-98699-8
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 840 Seiten, E-Book

Pediatric Hematology is a comprehensive and succinctreferenced text on the diagnosis and treatment of blood diseases inchildhood. It provides a ready source of reference for all theconditions likely to be encountered in day-to-day clinicalpractice. For each condition, the authors give helpful advice ondifferential diagnoses and clinical management. This third editionhas been extensively updated throughout, in light of recentdevelopments in this rapidly advancing area of medicine.
A well established textbook on the diagnosis and treatment ofblood disorders in childhood
* * A balanced and cutting edge referenced text on all aspects ofdiagnosis and treatment
* Easy to use, practically organized, with essential aspects ofbiology included within each chapter
* International editorial and contributor team--representinga wide geographical and chronological range
Whether you are an established sub-specialist in pediatrichematology/oncology, a pediatrician, a trainee or nursingspecialist, this book will answer all your questions about benignand malignant disorders of the blood in children and youngadults.

Autoren/Hrsg.

Arceci, Robert J.

Hann, Ian M.

Smith, Owen P.

Weitere Mitwirkende

Hoffbrand, Victor

Inhaltsverzeichnis

Section 1: The Scientific Basis.
1 Hematopoiesis: an introduction (Hugh J.M. Brady).
Section 2: Marrow Failure Syndromes.
2 Failure of red cell production (Sarah E. Ball).
3 Inherited bone marrow failure syndromes (YigalDror).
4 Acquired aplastic anemia (Juliana Teo and YigalDror).
Section 3: Red Cell Disorders.
5 Disorders of iron metabolism: iron deficiency, iron overloadand the sideroblastic anemias (Andrew M. Will).
6 Megaloblastic anemia and disorders of cobalamin and folatemetabolism (Eric J. Werner).
7 Nonimmune neonatal anemias (Brenda E.S. Gibson andChristina Halsey).
8 Immune hemolytic anemias (Bertil Glader).
9 Disorders of erythrocyte metabolism including porphyria(Lawrence Wolfe and Peter E. Manley).
10 Sickle cell disease (Corrina McMahon).
11 Hemoglobin variants and the rarer hemoglobin disorders(Andreas E. Kulozik).
12 Red cell membrane abnormalities (Patrick G.Gallagher).
13 Thalassemias (Nancy F. Olivieri and David J.Weatherall).
Section 4: Granulocyte Disorders.
14 Disorders of granulopoiesis and granulocyte function(Arian Laurence, Pratima Chowdary and Philip Ancliff).
15 Histiocytic disorders (Amir H. Shahlaee and Robert J.Arceci).
16 Acute myeloid leukemia (Leslie S. Kean, Robert J. Arceciand William G. Woods).
17 Chronic myeloid leukemia (Irene A.G. Roberts and InderjeetS. Dokal).
18 Myelodysplastic syndromes (David K.H. Webb).
Section 5: Lymphocyte Disorders.
19 Primary and acquired immunodeficiency (Andrew R. Gennery,Adam H.R. Finn and Andrew J. Cant).
20 Clinical features and therapy of lymphoblastic leukemia(Owen P. Smith and Ian M. Hann).
21 Lymphomas (O.B. Eden and Ross Pinkerton).
Section 6: Platelet Disorders.
22 Inherited and congenital thrombocytopenia (Owen P.Smith).
23 Idiopathic thrombocytopenic purpura (Paul Imbach).
24 Thrombocytosis (Christof Dame).
25 Platelet function disorders (Alan D. Michelson).
Section 7: Coagulation Disorders.
26 Hemophilia A and B (Judith Smith and Owen P.Smith).
27 von Willebrand disease (David Lillicrap).
28 Rare congenital hemorrhagic disorders (Nigel S. Key andMargaret A. Heisel-Kurth).
29 Acquired disorders of hemostasis (Elizabeth A. Chalmers,Michael D. Williams and Angela Thomas).
30 Bleeding in the neonate (Elizabeth A. Chalmers).
31 Thromboembolic complications in children (Mary Bauman andM. Patricia Massicotte).
Section 8: Supportive Therapy.
32 Blood components and fractionated plasma products:preparation, indications and administration (Nancy Robitailleand Heather A. Hume).
33 Hazards of transfusion (Naomi L.C. Luban and Edward C.C.Wong).
34 Management of infection in children with bone marrow failure(Subarna Chakravorty and Ian M. Hann).
Section 9: Secondary Problems.
35 Hematologic effects of systemic disease and nonhematopoietictumors (Angela Thomas)
36 Lysosomal storage disorders (Brad T. Tinkle and Gregory A.Grabowski).
37 Reference values (Paula S. Simpkin and Roderick F.Hinchliffe).
Index.

Über Autor(innen)

Professor Robert Arceci is a world leader in the care ofchildren with leukaemia and especially acute myeloid leukaemia. Heedits the main Paediatric Haematology and Oncology journal,'Pediatric Blood & Cancer' and his research ismainly into new agents for leukaemia therapy and the scientificbasis for their actions.
Professor Ian Hann is chair of the national NRCN taskforce on ALL. He is associate medical director of Great OrmondStreet Hospital (GOS) and Professor and academic lead in PaediatricHaematology and Oncology at GOS and the Institute of Child Health.He coordinates the current national trial in ALL (ALL trial 2003)and is national coordinator of the international trial in infantleukaemia - Interfant. He is also Editor of the BritishJournal of Haematology.
Professor Owen Smith is academic lead for PaediatricHaematology and Oncology at the National Children's Hospitaland Trinity College, Dublin. He is a world expert on Shwachmann'ssyndrome and has carried out world-ranking research on protein C.He is national coordinator for UK and Ireland of the Internationalrelapsed AML trial.